Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in Hong Kong
2 of 3 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingA Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- Where
- Hksar
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06351631 · EU 2023-506996-89-00 - Phase 2Taking peopleRopeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 20
- Run by
- The University of Hong Kong
See details and how to joinNCT06770842